Manuel Mendizabal

25PUBLICATIONS
93CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modellingMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 03, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma: BAVENO VII Criteria Still Needs to Be Updated.

Federico Piñero, Margarita Anders, Leonardo da Fonseca

|Apr 10, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis.

Federico Piñero, Margarita Anders, Carla Bermudez

|Nov 06, 2024
Have CFTR modulators changed the need for liver and lung transplantation among patients with cystic fibrosis? An analysis of the UNOS database.

Manuel Mendizabal, Claire Cywes, Nicolas Muñoz

|Apr 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

Winston Dunn, Yanming Li, Ashwani K Singal

|Nov 23, 2022
Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries.

Fernando Bessone, Antonella Ferrari, Nelia Hernandez

|Oct 10, 2022
Reply.

Manuel Mendizabal, Nicolás Ducasa, Paula Benencio

Pageof 5

Frequent Collaborators

11 joint publications

Ezequiel Ridruejo

6 joint publications

Federico Piñero

3 joint publications

Marcelo Silva

3 joint publications

Sebastian Marciano